Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to national cholesterol education program treatment goals

被引：16

作者：

Davidson, MH

Nawrocki, JW

Weiss, SR

Schwartz, SL

Lupien, PJ

Jones, PH

Haber, HE

Black, DM

机构：

[1] WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, ANN ARBOR, MI 48105 USA

[2] SAN DIEGO ENDOCRINE & MED CLIN, SAN DIEGO, CA USA

[3] DIABET & GLANDULAR RES CLIN, SAN ANTONIO, TX USA

[4] LIPID RES CTR, Ste Foy, PQ, CANADA

[5] BAYLOR COLL MED, HOUSTON, TX 77030 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1997年 / 80卷 / 03期

关键词：

D O I：

10.1016/S0002-9149(97)00360-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atorvastatin is a highly efficacious hydroxymethylglutaryl-coenzyme A reductase inhibitor that has been shown to reduce low-density lipoprotein cholesterol by 40% to 60%. Monotherapy with atorvastatin (10 to 80 mg/day) is well-tolerated, convenient, and appears to be effective for achieving National Cholesterol Education Program treatment goals in most patients, regardless of risk status.

引用

页码：347 / +

页数：1

共 5 条

[1]

[Anonymous], 1994, CIRCULATION

[2] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].

BakkerArkema, RG ;

Davidson, MH ;

Goldstein, RJ ;

Davignon, J ;

Isaacsohn, JL ;

Weiss, SR ;

Keilson, LM ;

Brown, WV ;

Miller, VT ;

Shurzinske, LJ ;

Black, DM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133

[3] Task force 4. Efficacy of risk factor management [J].

Forrester, JS ;

Merz, CNB ;

Bush, TL ;

Cohn, JN ;

Hunninghake, DB ;

Parthasarathy, S ;

Superko, HR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :991-1006

[4] Inadequate treatment with HMG-CoA reductase inhibitors by health care providers [J].

Marcelino, JJ ;

Feingold, KR .

AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06) :605-610

[5] REDUCTION OF LDL CHOLESTEROL BY 25-PERCENT TO 60-PERCENT IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA BY ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR [J].

NAWROCKI, JW ;

WEISS, SR ;

DAVIDSON, MH ;

SPRECHER, DL ;

SCHWARTZ, SL ;

LUPIEN, PJ ;

JONES, PH ;

HABER, HE ;

BLACK, DM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) :678-682

← 1 →